$BSEM News
Last published 1d ago
- 1d agoBSEMBioStem Technologies, Inc. - EX-99.1Earnings ReleasesForm 8-K - Current report - Item 2.02 Item 9.01
- 2w agoBSEMBioStem Technologies to Host Third Quarter 2026 Financial Results Conference Call on November 12, 2026GlobeNewswirePOMPANO BEACH, Fla., Oct. 29, 2026 (GLOBE NEWSWIRE) -- BioStem Technologies, Inc. (NASDAQ:BSEM) ("BioStem" or the "Company"), a leading regenerative medicine company focused on the development,
- 1mo agoBSEMBioStem Technologies’ CEO and COO Invest $1 Million in Cash Through Exercise of Stock OptionsGlobeNewswirePOMPANO BEACH, Fla., Oct. 08, 2026 (GLOBE NEWSWIRE) -- BioStem Technologies, Inc. (NASDAQ:BSEM) ("BioStem" or the "Company"), a leading regenerative medicine company focused on the development,
- 1mo agoBSEMTerminal1, the operating system built for public companies, announced today that BioStem Technologies, Inc. (NASDAQ: BSEM) has joined the Terminal1 platformGlobeNewswireWest Palm Beach, Sept. 21, 2026 (GLOBE NEWSWIRE) -- Terminal1, the operating system built for public companies, announced today that BioStem Technologies, Inc. (NASDAQ:BSEM) has joined the Terminal1 platform.
- 1mo agoBSEMBioStem Technologies Secures Up to $40 Million in a Committed Equity FacilityGlobeNewswirePOMPANO BEACH, Fla., Sept. 18, 2026 (GLOBE NEWSWIRE) -- BioStem Technologies, Inc. (NASDAQ:BSEM) ("BioStem" or the "Company"), a leading regenerative medicine company focused on the development,
- 2mo agoBSEMBioStem Technologies Opens Hospital Access for VENDAJE® and VENDAJE AC® Through Vizient and PremierGlobeNewswirePOMPANO BEACH, Fla., Sept. 04, 2026 (GLOBE NEWSWIRE) -- BioStem Technologies Inc. (NASDAQ:BSEM) ("BioStem" or the "Company"), a leading regenerative medicine company focused on the development,
- 2mo agoBSEMBioStem Technologies to Present at the H.C. Wainwright 28th Annual Global Investment ConferenceGlobeNewswirePOMPANO BEACH, Fla., Sept. 03, 2026 (GLOBE NEWSWIRE) -- BioStem Technologies Inc. (NASDAQ:BSEM) ("BioStem" or the "Company"), a leading regenerative medicine company focused on the development,
- 3mo agoBSEMBioStem Technologies to Present at the Sidoti MicroCap ConferenceGlobeNewswirePOMPANO BEACH, Fla., Aug. 14, 2026 (GLOBE NEWSWIRE) -- BioStem Technologies Inc. (NASDAQ:BSEM) ("BioStem" or the "Company"), a leading regenerative medicine company focused on the development,
- 3mo agoBSEMBioStem Technologies Reports Second Quarter 2026 Financial ResultsGlobeNewswireGenerates 29% sequential revenue growth, increasing to $7.9 million;Raises full-year 2026 revenue guidanceUplists to Nasdaq Capital Market POMPANO BEACH, Fla., Aug. 12, 2026 (GLOBE NEWSWIRE) -- BioStem Technologies,
- 5mo agoBSEMBioStem Technologies Announces Notice of Allowance for Four U.S. Design Patent Applications Covering Fenestrated Human Placental Allografts and One European PatentGlobeNewswirePompano Beach, FL, May 20, 2026 (GLOBE NEWSWIRE) -- BioStem Technologies®, a leading regenerative medicine company focused on developing and commercializing placental-derived biologics, today announced that the
- 9mo agoBSEMBioStem Technologies Advances Entry into the Acute Wound Care Market with Acquisition of BioTissue Holdings' Surgical and Wound Care BusinessGlobeNewswireAccelerates expansion of BioStem's commercial organization through integration of an experienced national sales force Expands access to major GPO networks, strengthening BioStem's position across hospital settings
- 1y agoBSEMBioStem Technologies Provides Comments on CMS CY 2026 Final Medicare Reimbursement Rule Changes for Skin SubstitutesGlobeNewswirePOMPANO BEACH, Fla., Nov. 05, 2025 (GLOBE NEWSWIRE) -- BioStem Technologies, Inc. (OTC:BSEM), a leading MedTech company specializing in placental-derived biologics for advanced wound care, today commented on the
- 1y agoBSEMBioStem Technologies to Host Second Quarter 2025 Financial Results Conference Call on August 14, 2025GlobeNewswirePOMPANO BEACH, Fla., July 30, 2025 (GLOBE NEWSWIRE) -- BioStem Technologies Inc. (OTC:BSEM), a leading MedTech company focused on the development, manufacture, and commercialization of placental-derived products for
- 2y agoBSEMBiostem Technologies, Inc. (BSEM) Q4 2023 Earnings Call TranscriptEarnings Call Transcripts
- 3y agoBSEMBioStem Awarded a Spot on ECAT, DAPA, and FSS Contract Vehicles Through SDVOSB, LovellGlobeNewswirePENSACOLA, FL, Sept. 06, 2023 (GLOBE NEWSWIRE) -- Lovell® Government Services (‘Lovell') and BioStem Technologies (POMPANO BEACH, FL, ‘BioStem') announced today that they have successfully listed BioStem on key
- 3y agoBSEMBioStem Technologies Commends OIG's Recommendation for CMS to Address ASP Reporting Requirements for Skin Substitute ProductsGlobeNewswirePOMPANO BEACH, FLORIDA., March 23, 2023 (GLOBE NEWSWIRE) -- BioStem Technologies ("BioStem" or the "Company") (OTCQB:BSEM), a leading provider of innovative regenerative medicine solutions, is commending the U.S.
- 3y agoBSEMBioStem Technologies to Acquire Majority of Assets of Auxocell Laboratories, Inc.GlobeNewswirePOMPANO BEACH, FLORIDA., March 07, 2023 (GLOBE NEWSWIRE) -- BioStem Technologies Inc. ("BioStem" or the "Company") (OTCQB:BSEM), announced today that it has entered into an Agreement to acquire the majority of the
- 3y agoBSEMBioStem Technologies Enters Into a Share Exchange AgreementGlobeNewswireThe Company will Acquire Back 10% of Issued and Outstanding Shares of its Non-Wholly Owned Subsidiary and Manufacturing Division POMPANO BEACH, FLORIDA., Feb. 14, 2023 (GLOBE NEWSWIRE) -- BioStem Technologies Inc.
- 3y agoBSEMCenter for Medicare Services Established National Pricing of VENDAJETM in All MAC regionsGlobeNewswirePricing Provides VENDAJETM Reimbursement in All MAC Regions POMPANO BEACH, FLORIDA., Jan. 24, 2023 (GLOBE NEWSWIRE) -- BioStem Technologies Inc. (OTCQB:BSEM), a leading regenerative medicine company focused on the
- 3y agoBSEMBioStem Technologies Announces Up-Listing to the OTCQB Venture MarketGlobeNewswirePOMPANO BEACH, FLORIDA., Dec. 16, 2022 (GLOBE NEWSWIRE) -- BioStem Technologies Inc. (OTCQB:BSEM), a leading regenerative medicine company focused on the development, manufacture, and commercialization of placental
- 5y agoBSEMBioStem Technologies Announces Veterans Day Fundraiser to Support America's VetDogs®GlobeNewswirePompano Beach, Fl., Nov. 01, 2021 (GLOBE NEWSWIRE) -- BioStem Technologies, Inc. and its subsidiary Blue Tech Industries, Inc. (d/b/a BioStem Life Sciences), a Certified VOSB (Veteran-Owned Small Business), are proud to announce a 2021 Veterans Day Fun
- 5y agoBSEMBioStem Technologies Reports Record Breaking Second Quarter SalesGlobeNewswireCompany on Pace to Exceed 2020 Revenues in 2021 Pompano Beach, Fl., Aug. 25, 2021 (GLOBE NEWSWIRE) -- BioStem Technologies, Inc. (OTC:BSEM) ("BioStem" or the "Company"), a leading life sciences company specializing in perinatal tissue allografts
- 5y agoBSEMBioStem Technologies, Inc., Announces the Engagement of Biologics Consulting To Support FDA Strategies and Submissions.GlobeNewswirePompano Beach, Fl., July 27, 2021 (GLOBE NEWSWIRE) -- BioStem Technologies, Inc. (OTC:BSEM) ("BioStem" or the "Company"), a pre-clinical-stage biotechnology company focused on harnessing elements of perinatal tissue for use in regenerative therapies; a
- 5y agoBSEMBioStem Technologies, Inc. Awarded Q Code for VENDAJE® Product Line From CMS.GlobeNewswirePompano Beach, Fl., July 23, 2021 (GLOBE NEWSWIRE) -- BioStem Technologies, Inc. (OTC:BSEM) ("BioStem" or the "Company"), a pre-clinical-stage biotechnology company focused on harnessing elements of perinatal tissue for use in regenerative therapies; a
- 5y agoBSEMBioStem Technologies Announces Filing of 2021 First Quarter Financial ReportsGlobeNewswirePompano Beach, Fl., May 24, 2021 (GLOBE NEWSWIRE) -- BioStem Technologies, Inc. (OTC:BSEM) ("BioStem" or the "Company"), a leading life sciences company specializing in perinatal tissue allografts for use in regenerative therapies, today announced that
- 5y agoBSEMBioStem Technologies, Inc., Announces the Addition of Three Key Scientific Advisory Board MembersGlobeNewswirePompano Beach, Fl., April 20, 2021 (GLOBE NEWSWIRE) -- BioStem Technologies, Inc. (OTC:BSEM) ("BioStem" or the "Company"), a pre-clinical-stage biotechnology company focused on harnessing elements of perinatal tissue for use in regenerative therapies;